Short description
Intellect Neurosciences is engaged in the R&D of disease-modifying drugs for the prevention of neurological disorders such as Alzheimer's.
Description
Intellect Neurosciences Inc. is a New York based biopharmaceutical company engaged in the discovery and development of a new breed of innovative “disease-modifying” therapeutic drugs designed to slow, arrest and ultimately prevent Alzheimer's disease and other serious neurological disorders.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
New York, New York, United States, North America
Founded on
January 1, 2005
Exited on
September 9, 2005
Went public on
September 9, 2005
Delisted on
November 30, 2018
Stock symbol
ILNS
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$56378 - 90123
Sign in for full access